Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

25.0%

4 terminated/withdrawn out of 16 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

31%

5 trials in Phase 3/4

Results Transparency

70%

7 of 10 completed trials have results

Key Signals

2 recruiting7 with results

Enrollment Performance

Analytics

Phase 2

6(37.5%)

Phase 1

4(25.0%)

Phase 3

4(25.0%)

N/A

1(6.3%)

Phase 4

1(6.3%)

16Total

Phase 2(6)

Phase 1(4)

Phase 3(4)

N/A(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT06600412Phase 2Recruiting

The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease.

Role: collaborator

NCT06436911Phase 1Completed

To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA

Role: collaborator

NCT05188729Phase 2Completed

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Role: collaborator

NCT05927649Phase 1Completed

A TQTc Study for Omaveloxolone

Role: collaborator

NCT05909644Phase 1Completed

An Open-label DDI Study of Omaveloxolone in Healthy Subjects

Role: collaborator

NCT05561764Phase 4Terminated

Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

Role: collaborator

NCT05003310Not ApplicableRecruiting

ConsideRAte Study - Splenic Stimulation for RA

Role: collaborator

NCT04731298Phase 2Terminated

Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.

Role: collaborator

NCT06125717Phase 1Completed

Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP

Role: collaborator

NCT01593254Phase 2Completed

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

Role: collaborator

NCT02349386Phase 2Terminated

Maintaining Suppression of Testosterone With Transdermal Estradiol Gel

Role: collaborator

NCT02725593Phase 3Completed

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

Role: collaborator

NCT03029247Phase 2Completed

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

Role: collaborator

NCT03184987Phase 3Completed

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

Role: collaborator

NCT03815318Phase 3Completed

Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A

Role: collaborator

NCT03202004Phase 3Withdrawn

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

Role: collaborator

All 16 trials loaded